These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15307008)

  • 21. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
    Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
    Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV exposure through contact with body fluids.
    Prescrire Int; 2012 Apr; 21(126):100-1, 103-5. PubMed ID: 22515138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
    Cardo DM; Culver DH; Ciesielski CA; Srivastava PU; Marcus R; Abiteboul D; Heptonstall J; Ippolito G; Lot F; McKibben PS; Bell DM
    N Engl J Med; 1997 Nov; 337(21):1485-90. PubMed ID: 9366579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.
    Tokars JI; Marcus R; Culver DH; Schable CA; McKibben PS; Bandea CI; Bell DM
    Ann Intern Med; 1993 Jun; 118(12):913-9. PubMed ID: 8387737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis.
    Muller WJ; Chadwick EG
    Infect Dis Clin North Am; 2018 Mar; 32(1):91-101. PubMed ID: 29406979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postexposure prophylaxis for HIV.
    Chin RL
    Emerg Med Clin North Am; 2010 May; 28(2):421-9, Table of Contents. PubMed ID: 20413023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HIV post-exposure prevention. Minutes are important--therefore PEP (postexposure prophylaxis) emergency set].
    MMW Fortschr Med; 2000; 142(3 Suppl):10. PubMed ID: 10893950
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
    Beekmann SE; Henderson DK
    Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational exposure to HIV: considerations for postexposure prophylaxis and prevention.
    McClinsey SC
    Nurs Clin North Am; 1999 Mar; 34(1):213-25. PubMed ID: 9922288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occupational and nonoccupational postexposure prophylaxis for HIV in 2009.
    Landovitz RJ
    Top HIV Med; 2009; 17(3):104-8. PubMed ID: 19675368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postexposure prophylaxis after HIV exposure. German-Austrian recommendations].
    Brodt HR
    Dtsch Med Wochenschr; 1998 Jun; 123(25-26 Suppl):S2-16. PubMed ID: 9672492
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of an Intervention to Increase Occupational Postexposure Prophylaxis in Sub-Saharan Africa.
    Courtenay-Quirk C; Selenic D; Lahuerta M; Kassa G; Murrman M; Bock N
    J Assoc Nurses AIDS Care; 2016; 27(5):727-30. PubMed ID: 27425796
    [No Abstract]   [Full Text] [Related]  

  • 34. [Postexposure prophylaxis after occupational exposure to HBV, HCV and HIV].
    Sarrazin U; Brodt R; Sarrazin C; Zeuzem S
    Radiologe; 2004 Feb; 44(2):181-94. PubMed ID: 14991139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-exposure prophylaxis revisited: new CDC guidelines. Centers for Disease Control and Prevention.
    Flexner C
    Hopkins HIV Rep; 1998 Jan; 10(1):2-3. PubMed ID: 11365132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis.
    Panlilio AL; Cardo DM; Grohskopf LA; Heneine W; Ross CS;
    MMWR Recomm Rep; 2005 Sep; 54(RR-9):1-17. PubMed ID: 16195697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV postexposure prophylaxis: Who should get it?
    Campos-Outcalt D
    J Fam Pract; 2006 Jul; 55(7):600-4. PubMed ID: 16822447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers.
    Uslan DZ; Virk A
    J Travel Med; 2005; 12(1):14-8. PubMed ID: 15996462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of needlestick injuries: a house officer who has a needlestick.
    Henderson DK
    JAMA; 2012 Jan; 307(1):75-84. PubMed ID: 22146902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant intolerability of efavirenz in HIV occupational postexposure prophylaxis.
    Wiboonchutikul S; Thientong V; Suttha P; Kowadisaiburana B; Manosuthi W
    J Hosp Infect; 2016 Apr; 92(4):372-7. PubMed ID: 26876748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.